has received consulting fees from Boehringer Ingelheim, GlaxoSmithKline, Madrigal, Novo Nordisk, ProSciento and Sagimet and research grants (to institution) from Merck Sharp & Dohme
Labeler & Regulatory Data Marketing Timeline Product Characteristics Code Structure Chart Product Details What is NDC 70069-005
Courses with insufficient spacing ( 730 days)
For individuals who also manage type 2 diabetes or another metabolic condition alongside GLP-1 treatment, any medication change carries additional variables that may be worth monitoring more closely
Key prevention strategies include systematically rotating injection sites each week, allowing the medication to reach room temperature before injecting, ensuring proper injection technique, cleaning the skin thoroughly before administration, and avoiding areas with visible skin changes or previous reactions